United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read Pharma Industry News Kinnate Biopharma agrees to merger with XOMA, boosting shareholder value and advancing cancer research Kinnate Biopharma Inc. (Nasdaq: KNTE), a leading clinical-stage precision oncology company, has announced a definitive merger agreement with… byPallavi MadhirajuFebruary 18, 2024